Kemp Paul
Intercytex Group Plc, Innovation House, Manchester, UK.
Regen Med. 2006 Sep;1(5):653-69. doi: 10.2217/17460751.1.5.653.
If the song by the international popstar Sting is to be relied upon, 'History will teach us nothing'. At the risk of contradicting a one-time schoolteacher, I believe the reverse is true for regenerative medicine. In fact, I think we dismiss the past at our peril. In this review, I aim to trace the history of regenerative medicine to date. I will examine parallels with other areas of medicine and show how commercial, technical and socio/economic factors have influenced the pace and direction of the sector's evolution. I will discuss how, by learning from the past, those involved in regenerative medicine are reinventing their sector for the better. In conclusion, I will evaluate the current state of the industry, suggest what the future may hold and explain why I believe regenerative medicine is about to 'come of age'.
如果要相信国际流行歌星斯汀的那首歌,“历史不会教给我们任何东西”。冒着与曾经的一名教师观点相悖的风险,我认为再生医学的情况恰恰相反。事实上,我觉得我们无视过去会自冒风险。在这篇综述中,我的目的是追溯再生医学迄今为止的历史。我将审视与医学其他领域的相似之处,并展示商业、技术以及社会/经济因素是如何影响该领域发展的速度和方向的。我将讨论再生医学领域的从业者如何通过汲取过去的经验,将该领域重塑得更好。最后,我将评估该行业的现状,推测未来的发展趋势,并解释我认为再生医学即将“走向成熟”的原因。